Trials / Completed
CompletedNCT06110702
Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms
Randomized Trial on the Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms During the COVID19 Quarantine: a Psychometric Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- University of Pisa · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The Eye Movement Desensitization and Reprocessing Protocol (EMDR) was first developed by Francine Shapiro in 1987 and can be adapted for online and in presence administration. The aim of this study is to assess if a EMDR program (administered both online and in presence, depending on different conditions of patients) may help people recruited from general population suffering from COVID19 second (November 2021 to February 2022) and third (March 2022 to May 2022) quarantine in improving post-traumatic stress (PTSD) and obsessive-compulsive-related (OCD) symptoms, as well as disgust, guilt, shame and their subjective unit of distress (SUD) and validity of cognition (VoC) levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | EMDR | Eye movement Desensitization and Reprocessing (as described in the 8-phases protocol), administered both online or in presence. |
Timeline
- Start date
- 2021-10-10
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2023-11-01
- Last updated
- 2024-04-16
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06110702. Inclusion in this directory is not an endorsement.